AFT Pharmaceuticals: NZ$12m Equity Raise
AFT Pharmaceuticals NZ$12m Equity Raise RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) has announced that it is undertaking an NZ$12m equity raise to...
229 Views
AFT Pharmaceuticals: Our First Prescription
AFT Pharmaceuticals Our First Prescription RESEARCH INSIGHTS We add AFT Pharmaceuticals (AFT) to our Research Insights series — a multi-national...
273 Views
AFT Pharmaceuticals - Solid FY20 results
AFT Pharmaceuticals recently reported its FY20 results. Operating revenue grew by a strong 24.0% year-on-year to NZ$105.6m as there was at least...
154 Views
AFT Pharmaceuticals - A strong start to FY20
AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that currently sells over 130 prescription specialty generics and OTC...
826 Views
AFT Pharmaceuticals - Margins improving
AFT Pharmaceuticals recently reported its H119 results. Operating revenue grew 4.1% compared to H118 and was negatively affected by the divestment...
133 Views